妊娠合并甲状腺功能减退症经激素替代治疗的妊娠结局探讨

发布时间：2019-05-05 08:05

【摘要】：目的分析妊娠合并甲状腺功能减退症经激素替代治疗的妊娠结局。方法入选此研究中的60例研究对象均为我院于2016年收治的妊娠合并甲状腺功能减退症孕妇,30例孕妇为亚临床加减(A组),30例孕妇为临床加减(B组),两组患者均选择激素替代治疗方法,随后选取同期体检80例健康孕妇(对照组),对三组孕妇的妊娠结局进行对比。结果 B组患者剖宫产率高于A组和对照组,同时胎膜早破发生率高于对照组,数据间通过比,差异有统计学意义(P0.05),而三组娠期高血压、妊娠期糖尿病、产后出血、羊水较少发生率、早产率、新生儿窒息率、低体重儿发生率以及出生体重经对比,差异无统计学意义(P0.05)。结论妊娠合并甲状腺功能减退症孕妇选择规范性激素替代治疗能够将甲状腺功能予以改善,同时减少不良妊娠结局产生影响。
[Abstract]:Objective to analyze the pregnancy outcome of hormone replacement therapy in pregnancy with hypothyroidism. Methods 60 cases of pregnant women with hypothyroidism in 2016 were enrolled in this study, 30 cases were subclinical addition and subtraction (group A), 30 cases were clinical addition and subtraction (group B), 30 cases were subclinical addition and subtraction (group A), 30 cases were pregnant women with hypothyroidism (group B), and 30 cases were pregnant women with hypothyroidism. Two groups of patients selected hormone replacement therapy, and then selected 80 healthy pregnant women in the same period (control group) to compare the pregnancy outcomes of three groups of pregnant women. Results the rate of cesarean section in group B was higher than that in group A and control group, and the incidence of premature rupture of membranes in group B was higher than that in control group (P 0.05), while the incidence of premature rupture of membranes in group B was higher than that in group A and control group (P0.05). There was no significant difference in the incidence of oligohydramnios, premature birth rate, neonatal asphyxia, low birth weight and birth weight (P0.05). Conclusion the choice of normative hormone replacement therapy for pregnant women with hypothyroidism can improve thyroid function and reduce adverse pregnancy outcome.
【作者单位】：成都市第二人民医院妇产科;
【分类号】：R714.256

【相似文献】